. Primary mouse wild-type (WT) and tauknockout (KO) forebrain neurons, and secondary cultures of wild-type mouse glia were treated for 12 h with Ab 1-42 , Ab 3(pE)-42 , or 5% Ab 3(pE)-42 plus 95% Ab , which were oligomerized for 24 h at 5 mM before dilution into culture media. a, Cells were exposed to calcein-AM and imaged live by epifluorescence microscopy to assay viability 16 . Extensive death and detachment of cells were observed only for wild-type neurons treated with Ab 3(pE)-42 or the 5% Ab 3(pE)-42 plus 95% Ab . b, Following peptide treatment, cell viability was analysed by the XTT plate reader assay 17 . Note the robust cytotoxicity of Ab 3(pE)-42 containing solutions at concentrations as low as 0.5 mM, unless Ab 3(pE)-42 and Ab were incubated separately during oligomerization (P , 0.01; yellow stars signify statistical significance of the indicated bar graphs versus vehicle controls; black stars signify statistical significance between the indicated bar graph pairs; mean 6 standard error of the mean (s.e.m.), n 5 9 replicates from 3 independent experiments).
OD 450 nm /OD 490 nm ratio was for 5% pE-Ab, which peaked similarly to Ab 3(pE)-42 . Ab 3(pE)-42 , Ab and 5% pE-Ab thus oligomerized by different pathways.
To test whether distinct biological activities were coupled to these oligomerization differences, we compared cytotoxicity of the peptides towards cultured neurons or glia using calcein-AM and fluorescence microscopy 16 . Twelve hours of Ab 1-42 exposure had little effect on cell viability for wild-type or tau-knockout neurons, or wild-type glial cells ( Fig. 1a ). Contrastingly, most wild-type neurons died and detached from the substrate after exposure to Ab 3(pE)-42 or 5% pE-Ab. Tauknockout neurons and wild-type glia, which express little tau, were resistant to Ab 3(pE)-42 and 5% pE-Ab.
Cytotoxicity dose dependence was examined by incubating wildtype neurons for 24 h in oligomers comprising 0.1, 0.5 or 1 mM peptides, and using the 2,3-bis-(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay 17 (Fig. 1b ). Cells were unaffected by Ab 1-42 , but Ab 3(pE)-42 and 5% pE-Ab had substantial cytotoxicity at 0.5 mM and even more at 1.0 mM. Cytotoxicity of 5% pE-Ab required Ab 3(pE)-42 and Ab 1-42 to incubate together for 24 h before being added to cells. When they were incubated separately for 24 h and mixed together at a 1:19 molar ratio immediately before being applied to cells, they were not cytotoxic. A small amount of Ab 3(pE)-42 can thus markedly enhance the cytotoxicity of a large excess of Ab 1-42 , provided the two peptides oligomerize together.
Evidence for hybrid oligomers came from immunoprecipitation of various forms of amyloid-b using aggregation-dependent M64, which does not recognize Ab 3(pE)-42 (see Supplementary Fig. 4 for characterization of all anti-amyloid-b antibodies used, including M64). Immunoprecipitations were analysed on dot blots using 4G8, which equally recognizes Ab 3(pE)-42 and Ab , and anti-pE-Ab, which does not react with Ab 1-42 . M64 immunoprecipitated oligomers made from Ab or 5% pE-Ab, but it did not immunoprecipitate Ab 3(pE)-42 oligomers, nor monomers of either peptide ( Fig. 2a ). Because anti-pE-Ab reacted with material immunoprecipitated out of 5% pE-Ab, M64 pulled down hybrid peptide oligomers. Ab 3(pE)-42 accounted for ,16% of the amyloid-b in gel-filtered cytotoxic oligomers after 3 h of oligomerization, and steadily dropped to ,8% by 24 h (Fig. 2b ). Ab 3(pE)-42 thus acts as a template that initiates formation of cytotoxic oligomers.
Cytotoxicity was sensitive to oligomerization time ( Fig. 2c ). Baseline cytotoxicity was observed at all time points for Ab , and for 5% pE-Ab solutions in which Ab 3(pE)-42 and Ab 1-42 oligomerized separately. Pure Ab 3(pE)-42 killed ,50% of the cells after 24 h of oligomerization, but was virtually non-toxic at 0 h and after 96 h of oligomerization. The most cytotoxic solutions were 5% pE-Ab, in which the constituent peptides co-oligomerized for 24 h. These solutions killed ,60% of the cells within 24 h, and lower but robust cytotoxicity was observed at 96 h. Even the 0 h co-oligomers of 5% pE-Ab exhibited low, significant cytotoxicity. Co-incubated mixtures of 5% Ab 3(pE)-42 and 95% oligomers. a, Ab 3(pE)-42 and Ab 1-42 were incubated together at a 1:19 molar ratio (5% pE-Ab) for 24 h at 1 mM total amyloid-b, and were then immunoprecipitated (IP) with M64, a rabbit monoclonal antibody that specifically recognizes residues 3-7 (EFRH) of Ab 1-40 oligomers or fibrils. Additional samples that were immunoprecipitated included otherwise identically treated oligomers made from pure Ab 3(pE)-42 or Ab 1-42 , and monomeric versions of the two peptides. Immunoprecipitated oligomers were converted to monomers by lyophilization, solubilization with HFIP and dilution into PBS, and along with the other samples were dot blotted onto nitrocellulose and analysed using 4G8, a mouse monoclonal antibody that recognizes Ab 3(pE)-42 and Ab 1-42 equally well, and an antibody that specifically recognizes pE-Ab (see Supplementary Fig. 4 for characterization of all antibodies used here). Quantification of the dot blots using a LI-COR Odyssey imaging station indicated that the oligomers that were immunoprecipitated from the mixed peptide solution contained both Ab 3(pE)-42 and Ab 1-42 , at a molar ratio of ,1:10. b, Solutions containing 5% pE-Ab 3(pE)-42 and 95% Ab 1-42 were incubated for the indicated times, and then were fractionated by gel filtration. At each time point, fractions that eluted at 12.5 ml, where most cytotoxicity resided (see Fig. 3b ) were immunoprecipitated using anti-human amyloid-b (N), an amino-terminal-specific antibody that does not react with pE-Ab (data not shown). The immunoprecipitates were then lyophilized, resolubilized with HFIP, and quantitatively analysed on dot blots with 4G8 and anti-pE-Ab using the LI-COR Odyssey. The time-dependent decrease in the Ab 3(pE)-42 content of the immunoprecipitated oligomers implies that Ab 3(pE)-42 initiated formation of hybrid peptide oligomers. c, Ab 3(pE)-42 and Ab 1-42 oligomerized for 0, 24 and 96 h either separately or together as 1:19 mixtures, and then were added to primary wild-type neuron cultures for 24 h at a final concentration of 1 mM total amyloid-b. Following peptide treatment, cell viability was analysed by the XTT plate reader assay 17 . The most cytotoxic species observed were the hybrid oligomers after 24 h of oligomerization (P , 0.01; yellow stars signify statistical significance of the indicated bar graphs versus vehicle controls; black stars signify statistical significance between the indicated bar graph pairs; mean 6 s.e.m., n 5 6 or 9 replicates from 3 independent experiments for panel b or c, respectively).
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Ab 1-42 can therefore form oligomers whose cytotoxicity is both greater and more enduring than oligomers formed by Ab 3(pE)-42 alone.
To identify the co-oligomer size(s) that were cytotoxic, amyloid-b solutions were oligomerized for various times from 0-96 h before fractionation by gel filtration. Total amyloid-b in all fractions was determined using 4G8 dot blots that, as shown in Fig. 3a (for 5% pE-Ab) and Supplementary Fig. 5 (for Ab and Ab 3(pE)-42 ), illustrate the full fractionation range of the column but exclude most void volume fractions. Presumptive monomeric Ab 1-42 dominated initially and persisted at 3 h, but was nearly undetectable after 12 h. The 3 h time point also marked the appearance of Ab 1-42 oligomers, which gradually increased in size over the next 93 h. Ab 3(pE)-42 and 5% pE-Ab oligomerized differently. Putative monomers were present at 0 h for both samples, when slightly larger species, LNOs that possibly corresponded to dimers or trimers ( Supplementary Fig. 6 ), were also present. These persisted as the main species for 24 h for Ab 3(pE)-42 and for nearly 72 h for 5% pE-Ab, and later time points were dominated by larger aggregates that eluted in void volume fractions. Cytotoxicity was assayed for individual fractions of 5% pE-Ab that oligomerized for 24 h (Fig. 3b ). Most cytotoxicity was associated with the possible dimers/trimers that eluted at 12.5 ml, which at 425 nM peptide killed more than 60% of the cells. Low cytotoxicity was also observed at 554 nM peptide for the larger oligomers that eluted at 8.5 ml.
The marked enhancement of Ab 1-42 cytotoxicity by Ab 3(pE)-42 suggested a prion-like templating mechanism of Ab 1-42 misfolding initiated by Ab 3(pE)-42 . To test that hypothesis, 5% pE-Ab that oligomerized for 24 h was diluted into 19 volumes of monomeric Ab . A 24 h incubation of this mixture yielded 'serial passage 1', which was followed by two equivalent, sequential dilutions into monomeric Ab 1-42 to yield serial passages 2 and 3. A gradual loss of cytotoxicity was observed with successive passages, but even passage 3, which contained only 0.000625% Ab 3(pE)-42 , killed ,50% of the neurons within 24 h (Fig. 3c ). Serially passaged gel-filtration samples contained abundant material that eluted at 12.5 ml in passages 1-3, despite the progressive dilution of Ab 3(pE)-42 (Fig. 3d ). Ab 3(pE)-42 can therefore template formation of metastable, cytotoxic LNOs from excess Ab 1-42 , yielding potent bioactivity that can be serially passaged multiple times into monomeric Ab 1-42 without further addition of Ab 3(pE)-42 .
One possible explanation for why Ab 1-42 LNOs were inert is that they lacked sufficient properly sized oligomers. Accordingly, we altered the oligomerization protocol from 5 mM peptide for 24 h at 37 uC to 10 mM peptide for 30 min at 4 uC to obtain abundant Ab oligomers that eluted at 12.5 ml (Fig. 3e ). These LNOs were not cytotoxic ( Fig. 3f ), implying that they were structurally distinct from the putative dimers/trimers initiated by Ab 3(pE)-42 . This was confirmed by dot blots using M87, a conformation-sensitive anti-amyloid-b antibody, to compare the putative dimers/trimers used for the cytotoxicity assays shown in Fig. 3f . We first lyophilized aliquots of all the amyloid-b solutions, resuspended them with hexafluoroisopropanol (HFIP) to restore them to monomers, and then analysed them using 4G8. When parallel samples that were not lyophilized but were otherwise identical were analysed using M87, immunoreactivity was approximately twice as strong with LNOs made from Ab 1-42 versus those made from 5% pE-Ab ( Supplementary Fig. 7 ). Cytotoxic LNOs of 5% pE-Ab are thus structurally distinct from comparably sized LNOs of Ab 1-42 . filtration chromatography was used to fractionate 5% pE-Ab after oligomerization at 5 mM at 37 uC for 0-96 h. The resulting fractions were then converted to monomers using HFIP and analysed on dot blots using monoclonal antibody 4G8. Note the metastable oligomers with an average elution volume (V e ) of 12.5 ml. b, Isolated gel-filtration fractions from the 24 h time point were added to wild-type neuron cultures for 24 h, after which the cells were assayed for cell viability using XTT 17 . Robust cytotoxicity was associated only with the V e 5 12.5 ml fraction, although the V e 5 8.5 ml fraction had low, but statistically significant cell killing activity (P , 0.01; mean 6 s.e.m., n 5 9 replicates from 3 independent experiments). ND, not detected. c, Cytotoxic hybrid oligomers made by co-incubating a 1:19 ratio of Ab 3(pE)-42 :Ab 1-42 for 24 h at 5 mM were diluted into a 19-fold molar excess of freshly dissolved, monomeric Ab 1-42 , which was then incubated at 5 mM for another 24 h to yield serial passage 1. Two further iterations of this strategy yielded serial passages 2 and 3. The starting material and its serially passaged derivatives were added to wild-type neurons at 1 mM peptide for 24 h, after which cells were analysed using the XTT assay for cell viability 17 . Only a gradual loss of cytotoxicity was observed with each successive serial passage. d, Each serially passaged sample, as well as otherwise identically prepared oligomers made from pure Ab 1-42 , were fractionated by gel filtration and analysed on dot blots with 4G8. Note that all serially passaged samples contained metastable LNOs of V e 5 12.5 ml, which were absent from the pure Ab 1-42 samples. e, Ab 1-42 (10 mM) that was oligomerized for 30 min at 4 uC, and 5% Ab 3pE-42 plus 95% Ab 1-42 (5 mM) that was oligomerized for 24 h at 37 uC were fractionated by gel filtration and analysed on dot blots exactly using 4G8. Note the isolation of fractions with V e 5 12.5 ml from both preparations. f, Wildtype neurons were assayed for viability using the XTT plate reader assay 17 following 24 h of exposure to the indicated amyloid-b preparations. Note the minimal cytotoxicity of unfractionated Ab 1-42 and Ab 1-42 with V e 5 12.5 ml (P , 0.01, mean 6 s.e.m., n 5 9 replicates from 3 independent experiments). P , 0.01; yellow stars signify statistical significance of the indicated bar graphs versus vehicle controls; black stars and blue stars signify statistical significance between the indicated bar graph pairs; blue mean 6 s.e.m., n 5 9 replicates from 3 independent experiments for panels b, c and f.
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Several lines of evidence demonstrate in vivo relevance for the data described so far. First, we identified LNOs containing Ab 3(pE)-42 in three out of three Alzheimer's disease samples, based on gel filtration of human brain extracts followed by dot blots of resulting fractions with anti-pE-Ab and M87. In contrast, only one of three age-matched samples with normal neuropathological diagnoses was positive for Ab 3(pE)-42 ( Fig. 4a and Supplementary Fig. 8 ). Second, we crossed TBA2.1 mice 18 into a tau-knockout background 19 . By 3 months, TBA2.1 mice accumulated small amounts (40-100 ng g 21 brain weight) of Ab 3(pE)-42 , which formed primarily intraneuronal aggregates, and was associated with massive hippocampal neuron loss and gliosis 18 . Knocking out tau provided almost complete protection against neuron loss and glial activation (Fig. 4b ). Additional in vivo data are shown in Supplementary Fig. 9 . Long-term potentiation (LTP) of mouse hippocampal neurons in slice cultures was potently and equally inhibited by oligomers made from 5% Ab 3(pE)-42 or 100% Ab 3(pE)-42 , whereas Ab 1-42 oligomers had no effect on LTP. 1% Ab 3(pE)-42 provoked mild, but statistically insignificant LTP impairment ( Supplementary Fig. 9a ). To evaluate the effects of increased Ab 3(pE)-42 in animal models, we crossed mice with neuron-specific expression of human b-amyloid precursor protein (APP) harbouring Swedish and London mutations (hAPP SL ) 20 , with mice expressing human QC 21 . Nine-month-old double (hAPP SL /hQC) and single (hAPP SL ) transgenic mice were indistinguishable in terms of insoluble and soluble Ab x-42 levels, but the double transgenics had approximately twofold more insoluble Ab 3(pE)-42 and approximately ninefold more soluble Ab 3(pE)-42 than single transgenics ( Supplementary Fig.  9b ). Further analysis of the soluble Ab x-42 by the A4 assay 22 revealed an approximately eightfold excess of oligomers in the double versus single transgenics ( Supplementary Fig. 9c ). Double transgenics performed more poorly in Morris water maze tests ( Supplementary Fig. 9d ) and had reduced hippocampal immunoreactivity for the synapse marker, synaptophysin ( Supplementary Fig. 9e ). Finally, peri-hippocampal injection of 5% pE-Ab at 5 mM into APP SwDI /NOS2 2/2 Alzheimer's disease model mice 23 led 3-5 months later to the presence of plaques containing both pE-Ab and conventional amyloid-b. Comparable plaques were rarely seen in sham-injected Alzheimer's disease mice or in wild-type mice injected with 5% pE-Ab ( Supplementary Fig. 9f ). These collective in vivo results emphasize the physiological significance of the companion biochemical and cultured cell results.
Our studies provide new insights into Alzheimer's disease pathogenesis by demonstrating that hypertoxic amyloid-b oligomers can be triggered by small quantities of a specifically truncated and posttranslationally modified version of amyloid-b. Although some previous studies demonstrated that pE modification of amyloid-b considerably enhances its aggregation kinetics 13, 14, 24 , toxicity 12, 18, 25 and resistance to degradation 12 , a mechanistic explanation for the unique properties of pE-Ab has been lacking until now. Prior studies suggest coincident appearance of Ab 3(pE)-42 with development or progression of human Alzheimer's disease 26, 27 . Co-localization of QC and Ab 3(pE)-42 was found in cored plaques of vulnerable regions in Alzheimer's disease, and evidence was provided for axonal transport of Ab 3(pE)-x from QC-rich neuronal populations of the entorhinal cortex and locus coeruleus 28 . As LNOs containing Ab 3(pE)-42 are reasonably stable (Fig. 3a) , they might initiate tau-dependent cytotoxicity intracellularly during axonal transport 29 or extracellularly following release at remote hippocampal synapses 30 of projection neurons 28 . The Ab 3(pE)-42 -induced formation of toxic mixed oligomers provides a rationale for these previous observations, and the taudependent cytotoxicity of 5% pE-Ab establishes a new functional connection between amyloid-b and tau in Alzheimer's disease pathogenesis.
METHODS SUMMARY
Full descriptions of thioflavin T assays, cell culture, cell viability assays, procedures for oligomerization of amyloid-b peptides and their fractionation by gel-filtration chromatography, production and specificity of rabbit monoclonal anti-amyloid-b antibodies, immunoprecipitation, dot blots and western blots, generation of hAPP SL /hQC transgenic mice, LTP measurements of mouse hippocampal slice cultures, peri-hippocampal injection of 5% pE-Ab into Alzheimer's disease model mice, cultured cell and brain immunohistochemistry, and collection of human brain extracts are provided in Supplementary Methods. Supplementary Fig. 9 ) were fractionated by gel filtration, and analysed by dot blotting with anti-pE-Ab and M87. Note the appearance of pE-Ab in LNO fractions, including those that eluted at 12.4 ml, especially in the Alzheimer's disease samples. b, Three-month-old TBA2.1 mice generating Ab 3(pE)-42 18 show amyloid-b deposits (arrows), massive astrogliosis (GFAP) and neuron loss (Hem., haematoxylin nuclear staining), none of which are evident in comparably aged wild-type (WT) mice or TBA2.1/tau-knockout 19 (KO) hybrids.
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